Pheronym

Pheronym

Private
Woodland, CaliforniaFrontier & Industrial Techhttps://www.pheronym.com

Last Round

Grant

Jul 11, 2023

Total Funding Raised

$1.79M

Momentum Score

50 /100

Company Overview

Pheronym is an agricultural biotechnology company that provides non-toxic solutions for plant protection and pest management. The company's core technology involves using nematode pheromones to control the behavior and development of microscopic roundworms. Pheronym has developed two main products: Nemastim™, which enhances the effectiveness of beneficial nematodes in controlling insect pests, and PheroCoat™, a seed treatment designed to repel destructive plant-parasitic nematodes from crop roots. The company is actively engaged in research and development, has secured multiple patents, and has received significant grant funding from the National Science Foundation (NSF) and the USDA, in addition to seed-stage venture capital. Pheronym aims to provide farmers with sustainable and effective alternatives to conventional chemical pesticides.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Advanced Materials, Sustainable Materials

Business Model

B2B

Customer Profile

Government Contracts, Hardware Sales

AI Layer

Non-AI

Keywords

pheromone technologynematode controlbiological pest controlbiopesticidesseed treatmentnematode pheromonesag-biotechbeneficial nematodescrop protectionchemical pesticide alternativebiorationalssustainable agricultureagritechSmall Business Innovation ResearchSBIRCooperative Research and Development AgreementCRADA

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pheronym Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Pheronym Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantJul 11, 2023
SeedMay 11, 2021
AcceleratorApr 28, 2021
GrantJun 9, 2020
AcceleratorSep 14, 2017

Key People

Founding team and executive leadership

Karl Cameron Schiller

COO Cofounder

Founding Team

Fatma Kaplan

CEO Co-founder

Founding Team

Pheronym Investors

Notable investors and investment history

InvestorRounds
SVG Ventures|THRIVEAccelerator
IndieBioAccelerator
Sacramento AngelsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2025

    CEO Dr. Kaplan presenting at 'Pitch Perfect and Boost the EU Bioeconomy 2025'.

  • Oct 27, 2025

    CEO Dr. Fatma Kaplan to keynote at the Women and Allies in Entomology Breakfast.

Pheronym Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pheronym Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pheronym's valuation, stock price, and market status.

Firmographic Details

HeadquartersWoodland, California
Employee Range9
Year Founded2017
Last FundingJul 11, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.